FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to a method for manufacturing a cell-free hydrogel from Wharton's jelly of the human umbilical cord. A method of manufacturing a cell-free hydrogel from Wharton's jelly of the human umbilical cord for intra-articular use in order to restore damage to the articular cartilage, including obtaining a native umbilical cord, sterilization with a hydrogen peroxide solution, its preparation, fragmentation and homogenization, decellularization with sodium hydroxide followed by its neutralization with a solution of hydrochloric acid, washing and detached cells, neutralization with sodium hydroxide solution and re-centrifugation; lyophilization, then the resulting lyophilized matrix is solubilized by exposing the resulting matrix to pepsin in a solution of hydrochloric acid, after which the medium is neutralized by titration with sodium hydroxide to physiological pH values, under certain conditions.
EFFECT: above method allows to create a full-component matrix and hydrogel from the connective tissue of the human umbilical cord using the most physiological methods, which has regenerative properties to ensure the healing of cartilage and soft tissue injuries.
1 cl, 14 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MANUFACTURING CELL-FREE MATRIX FROM HUMAN UMBILIC CORD TO CREATE HIGHLY GENERATIVE WOUND COVERING | 2022 |
|
RU2795904C1 |
METHOD OF USING CELL-FREE LYOPHILISED HUMAN UMBILICAL CORD PRODUCT FOR WOUND HEALING | 2023 |
|
RU2816034C1 |
METHOD OF PRODUCING TISSUE-SPECIFIC MATRIX FOR TISSUE ENGINEERING OF CARTILAGE | 2019 |
|
RU2716577C1 |
HYALINE CARTILAGE REPAIR METHOD IN TREATMENT OF INTRAARTICULAR FRACTURES | 2008 |
|
RU2364360C1 |
THERAPY OF ARTHROSIS | 2007 |
|
RU2360691C1 |
BIOMATERIAL BASED ON CELL-FREE MATRIX PRODUCED BY HUMAN MESENCHYMAL STROMAL CELLS, METHOD FOR PREPARING THEREOF AND METHOD OF USING THEREOF TO STIMULATE REGENERATIVE PROCESSES | 2018 |
|
RU2718907C1 |
METHOD FOR CREATING TISSUE-ENGINEERING STRUCTURES BY BIOPRINTING WITH BIOINK FOR CARTILAGE TISSUE REGENERATION UNDER BODY CONDITIONS | 2021 |
|
RU2770558C2 |
METHOD FOR OBTAINING TISSUE-ENGINEERED PERICHONDRIUM TRANSPLANT BASED ON CELL SPHEROIDS | 2022 |
|
RU2807692C2 |
GRAFT-TISSUE-ENGINEERED PERICHONDRIUM FOR CARTILAGE RESTORATION OF SUBJECT | 2023 |
|
RU2822238C1 |
METHOD FOR EVALUATING COMPENSATORY MANIFESTATION AT AFFECTING ARTICULAR COMPONENTS IN ANIMALS UNDER CONDITIONS OF MODELING DESTRUCTIVE-DYSTROPHIC PROCESS | 2004 |
|
RU2271140C1 |
Authors
Dates
2021-04-05—Published
2020-09-16—Filed